Renin-Angiotensin System Gene Polymorphisms and Atrial Fibrillation
Top Cited Papers
- 6 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (13), 1640-1646
- https://doi.org/10.1161/01.cir.0000124487.36586.26
Abstract
Background— The activated local atrial renin-angiotensin system (RAS) has been reported to play an important role in the pathogenesis of atrial fibrillation (AF). We hypothesized that RAS genes might be among the susceptibility genes of nonfamilial structural AF and conducted a genetic case-control study to demonstrate this. Methods and Results— A total of 250 patients with documented nonfamilial structural AF and 250 controls were selected. The controls were matched to cases on a 1-to-1 basis with regard to age, gender, presence of left ventricular dysfunction, and presence of significant valvular heart disease. The ACE gene insertion/deletion polymorphism, the T174M, M235T, G-6A, A-20C, G-152A, and G-217A polymorphisms of the angiotensinogen gene, and the A1166C polymorphism of the angiotensin II type I receptor gene were genotyped. In multilocus haplotype analysis, the angiotensinogen gene haplotype profile was significantly different between cases and controls (χ2=62.5, P=0.0002). In single-locus analysis, M235T, G-6A, and G-217A were significantly associated with AF. Frequencies of the M235, G-6, and G-217 alleles were significantly higher in cases than in controls (P=0.000, 0.005, and 0.002, respectively). The odds ratios for AF were 2.5 (95% CI 1.7 to 3.3) with M235/M235 plus M235/T235 genotype, 3.3 (95% CI 1.3 to 10.0) with G-6/G-6 genotype, and 2.0 (95% CI 1.3 to 2.5) with G-217/G-217 genotype. Furthermore, significant gene-gene interactions were detected by the multifactor-dimensionality reduction method and multilocus linkage disequilibrium tests. Conclusions— This study demonstrates the association of RAS gene polymorphisms with nonfamilial structural AF and may provide the rationale for clinical trials to investigate the use of ACE inhibitor or angiotensin II antagonist in the treatment of structural AF.Keywords
This publication has 31 references indexed in Scilit:
- The G???217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese populationJournal Of Hypertension, 2003
- Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneityGenetic Epidemiology, 2003
- KCNQ1 Gain-of-Function Mutation in Familial Atrial FibrillationScience, 2003
- Angiotensinogen Gene Haplotype and HypertensionHypertension, 2003
- A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.Journal of Clinical Investigation, 1997
- Effects of lisinopril in patients with heart failure and chronic atrial fibrillationJournal of Cardiac Failure, 1995
- Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarctionJournal of Molecular and Cellular Cardiology, 1995
- Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.Journal of Clinical Investigation, 1993
- Myocardial fibrosis: functional significance and regulatory factorsCardiovascular Research, 1993
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986